课题基金 / 基金详情

Development of child-friendly oral formulations for drugs used in the maintenance therapy of childhood acute lymphoblastic leukemia

Development of child-friendly oral formulations for drugs used in the maintenance therapy of childhood acute lymphoblastic leukemia
开发用于儿童急性淋巴细胞白血病维持治疗的儿童友好型口服制剂
批准号：
343659
负责人：
Li Shyh-Dar
金额：
$25.06万
依托单位：
University of British Columbia
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-03-01 至 2019-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=343659&lang=en
关键词：
Anticancer Drug Delivery Lipid Nanoparticles Oral Pediatric Formulation Oro-Dispersible Formulation

项目摘要

项目成果

Li Shyh-Dar的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Durable remissions in children with acute lymphoblastic leukemia (ALL) require a 2- to 3-year maintenance therapy that includes daily or weekly home administration of oral 6-mercaptopurine, methotrexate and prednisone. The current clinical practice and av
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Validation and commercialization of an innovative analgesic for chronic pain
  • 批准号：
    408033
  • 项目类别：
    Operating Grants
  • 资助金额：
    $38.18万
  • 财政年份：
    2019
  • 负责人：
    Li Shyh-Dar
  • 依托单位：
    University of British Columbia
Heat-triggered Chemotherapy to Treat Refractory Breast Cancer at the Chest Wall
Benchmark Cellax, a proprietary nanoparticle formulation for docetaxel, against Taxotere to treat metastatic castration resistant prostate cancer
Targeted Cancer Chemotherapy by Nanoparticle-based Drug Delivery
海外基金